Research Articles

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth PM

COVID-19

Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan.

Rekart ML, Mun L, Aung A, Gomez D, Mulanda W, Kliescikova J, Sitali N, Rajabov A, Azamova S, Pirmahmadzoda B, Achar J, Alvarez JL, Greig J, Cros PD, Sinha A

Tuberculosis (TB)

The importance of information acquisition to settlement services literacy for humanitarian migrants in Australia.

Abood J, Green J, Polonsky MJ, Woodward K, Tadjoeddin Z, Renzaho AMN

The representation of women on Australian clinical practice guideline panels, 2010-2020.

Shalit A, Vallely L, Nguyen R, Bohren M, Wilson A, Homer CS, Vogel J

The cost-effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030.

Xiao Y, Hellard ME, Thompson AJ, Seaman C, Howell J, Scott N

Hepatitis B

Methods for living guidelines: early guidance based on practical experience. Paper 5: decisions on methods for evidence synthesis and recommendation development for living guidelines.

Fraile Navarro D, Cheyne S, Hill K, McFarlane E, Morgan RL, Murad MH, Mustafa RA, Sultan S, Tunnicliffe DJ, Vogel JP, White H, Turner T